GHCer could be transferred from cancer cells into non-tumor cells located in tumor microenvironment, such as endothelial cells, promoting angiogenesis [138], as well as into T cells, inhibiting IL-2, interferon-γ, and IL-4 secretion, promoting immunosuppression [25]. This evidence concerns the gene IL2 and neoplasm.